Literature DB >> 23186964

A novel GATA3 nonsense mutation in a newly diagnosed adult patient of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.

Kazutaka Nanba1, Takeshi Usui, Michikazu Nakamura, Yuko Toyota, Keisho Hirota, Tamiko Tamanaha, Sachiko-Tsukamoto Kawashima, Kanako Nakao, Akiko Yuno, Tetsuya Tagami, Mitsuhide Naruse, Akira Shimatsu.   

Abstract

OBJECTIVE: Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is an autosomal dominant disorder caused by a GATA3 gene mutation. Here we report a novel mutation of GATA3 in a patient diagnosed with HDR syndrome at the age of 58 with extensive intracranial calcification.
METHODS: A 58-year-old Japanese man showed severe hypocalcemia and marked calcification in the basal ganglia, cerebellum, deep white matter, and gray-white junction on computed tomography (CT). The serum intact parathyroid hormone level was relatively low against low serum calcium concentration. The patient had been diagnosed with bilateral sensorineural deafness in childhood and had a family history of hearing disorders. Imaging studies revealed no renal anomalies. The patient was diagnosed with HDR syndrome, and genetic testing was performed.
RESULTS: Genetic analysis of GATA3 showed a novel nonsense mutation at codon 198 (S198X) in exon 3. The S198X mutation leads to a loss of two zinc finger deoxyribonucleic acid (DNA) binding domains and is considered to be responsible for HDR syndrome.
CONCLUSION: We identified a novel nonsense mutation of GATA3 in an adult patient with HDR syndrome who showed extensive intracranial calcification.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23186964     DOI: 10.4158/EP12186.CR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  5 in total

1.  GATA3 mutation in a family with hypoparathyroidism, deafness and renal dysplasia syndrome.

Authors:  Zi-Yang Zhu; Qiao-Li Zhou; Shi-Ning Ni; Wei Gu
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

2.  Auditory and vestibular phenotypes associated with GATA3 mutation.

Authors:  Wade Wei-De Chien; Jennifer W Leiding; Amy P Hsu; Christopher Zalewski; Kelly King; Steven M Holland; Carmen Brewer
Journal:  Otol Neurotol       Date:  2014-04       Impact factor: 2.311

3.  A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome.

Authors:  Tetsuji Okawa; Masanori Yoshida; Takeshi Usui; Takahiro Kudou; Yasumasa Iwasaki; Kazuki Fukuoka; Norio Takahashi; Yuka Uehara; Yutaka Oiso
Journal:  BMC Endocr Disord       Date:  2015-10-30       Impact factor: 2.763

4.  A Mendelian randomization study of the effect of calcium on coronary artery disease, myocardial infarction and their risk factors.

Authors:  Lin Xu; Shi Lin Lin; C Mary Schooling
Journal:  Sci Rep       Date:  2017-02-14       Impact factor: 4.379

5.  A Novel De Novo GATA Binding Protein 3 Mutation in a Turkish Boy with Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome.

Authors:  Gül Yeşiltepe Mutlu; Heves Kırmızıbekmez; Akie Nakamura; Maki Fukami; Şükrü Hatun
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.